UGA Biopharma GmbH Information

UGA Biopharma was founded in 2009 in Hennigsdorf near Berlin, Germany. With its international team of experts, the company specializes in the development of monoclonal cell lines for the production of biologics and biosimilars. UGA Biopharma supports you from cell line development and bioprocess design to purification and analysis. We focus on your needs and develop customized solutions of the highest quality. In addition to our ready-to-use (R2U) cell lines for the expression of biosimilar candidates, our customized First CHOice® feed & media platform for cell culture offers you numerous options. UGA Biopharma's products have a proven track record of successful clinical trials and regulatory submissions. To learn more about UGA Biopharma, our development services and biosimilar products, please contact us.